FINDEX COM INC (Form: 3, Received: 06/25/2019 15:19:33)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

MEMBRADO MICHAEL M

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/12/2019

3. Issuer Name and Ticker or Trading Symbol

FINDEX COM INC [FIND]

(Last) (First) (Middle)

165 OLD POST ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___X___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

BEDFORD CORNERS, NY 10549

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,907,500	D
Common Stock	57,458,333	I	Through Sweet Swing Holdings, LLC. ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series RX-1 Convertible Preferred Stock ⁽²⁾⁽³⁾	⁽²⁾⁽³⁾	⁽²⁾⁽³⁾	Common Stock ⁽²⁾⁽³⁾⁽⁷⁾⁽⁸⁾	3,387,300 ⁽²⁾⁽³⁾⁽⁷⁾⁽⁸⁾	⁽²⁾⁽³⁾	D
Series RX-3 Preferred Stock Purchase Warrant ⁽⁴⁾⁽⁵⁾⁽⁶⁾	⁽⁴⁾⁽⁵⁾⁽⁶⁾	12/31/2029 ⁽⁴⁾⁽⁵⁾⁽⁶⁾	Common Stock ⁽⁴⁾⁽⁵⁾⁽⁶⁾⁽⁷⁾⁽⁸⁾	187,673,000 ⁽⁴⁾⁽⁵⁾⁽⁶⁾⁽⁷⁾⁽⁸⁾	⁽⁴⁾⁽⁵⁾⁽⁶⁾	D

Explanation of Responses:
(1)	This entity, a New York limited liability company, is owned 100% by the Reporting Person.
(2)	As part of the transactions described in Item 1.01 of the Issuer's Current Report on Form 8-K filed on June 12, 2019 (inclusive of the corresponding exhibits thereto, the "6-12 -19 Form 8-K" ) under the sub-heading "The Series RX-1 Preferred Stock Transactions," the Reporting Person received a total of 33,873 shares of Series RX-1 preferred stock (the "RX-1 Preferred Shares") in exchange for cash-based investment debt owed to the Reporting Person by the Issuer in the amount of $37,251. In the aggregate, the RX-1 Preferred Shares are convertible into 3,387,300 shares of Issuer common stock.
(3)	As a percentage of the number of shares of Issuer common stock issued and outstanding as of the date hereof, the total number of shares of Issuer common stock that would be held by the Reporting Person assuming that the RX-1 Preferred Shares were converted in full, and all of the shares of Issuer common stock issuable thereupon were so issued (without giving effect to any other outstanding Issuer warrants or convertible preferred shares, including those involving any other shares of Series RX-1 preferred stock) would be 8.92%.
(4)	As part of the transactions described in Item 1.01 of the Issuer's Current Report on Form 8-K filed on June 12, 2019 (inclusive of the corresponding exhibits thereto, the "6-12 -19 Form 8-K" ) under the sub-heading "The Series RX-3 Preferred Stock Warrant Transactions," the Reporting Person received two warrants to purchase a combined total of 187,673 shares of Issuer Series RX-3 preferred stock in exchange for debt owed to the Reporting Person by the Issuer for services rendered in the amount of $552,156 (the "RX-3 Warrants"). The RX-3 Warrants are not presently exercisable (or exercisable within 60 days) and are only exercisable in accordance with the express conditions and limitations set forth therein and disclosed more fully in the 6-12-19 Form 8-K, including their vesting pursuant to the Issuer's achievement of stated performance milestones, and, even then, only upon payment of the stated exercise prices. (Cont'd in Footnote 5)
(5)	In the aggregate, the RX-3 Warrants are exercisable (i) in the event that the Series RX-3 preferred stock is not automatically converted into shares of Issuer common stock prior to exercise, for the 187,673 shares of Series RX-3 preferred stock, which shall, in turn, be convertible in accordance with its terms into 187,673,000 shares of Issuer common stock, or (ii) in the event that the Series RX-3 preferred stock is automatically converted to shares of Issuer common stock prior to exercise, for 187,673,000 shares of Issuer common stock (directly).
(6)	As a percentage of the number of shares of Issuer common stock issued and outstanding as of the date hereof, the total number of shares of Issuer common stock that would be held by the Reporting Person assuming that (i) the RX-3 Warrants were exercised in full, and (ii) all of the shares of Issuer common stock issuable upon conversion of the shares of Series RX-3 preferred stock issuable pursuant to such RX-3 Warrants were so issued (without giving effect to any other outstanding Issuer warrants or convertible preferred shares, including those involving Series RX-3 preferred stock) would be 27.35%.
(7)	As a percentage of the number of shares of Issuer common stock issued and outstanding as of the date hereof, the total number of shares of Issuer common stock that would be held by the Reporting Person assuming that (i) the RX-1 Preferred Shares were converted in full, (ii) all of the shares of Issuer common stock issuable upon conversion of the RX-1 Preferred Shares were so issued, (iii) the RX-3 Warrants were exercised in full, and (iv) all of the shares of Issuer common stock issuable upon conversion of the shares of Series RX-3 preferred stock issuable pursuant to such RX-3 Warrants were so issued (without giving effect to any other outstanding Issuer warrants or convertible preferred shares, including those involving Series RX-1 preferred stock and Series RX-3 preferred stock) would be 27.62%.
(8)	As a percentage of the number of shares of Issuer common stock issued and outstanding, the total number of shares of Issuer common stock that would be held by the Reporting Person assuming that (i) the RX-1 Preferred Shares were converted in full, (ii) all of the shares of Issuer common stock issuable upon conversion of the RX-1 Preferred Shares were so issued, (iii) the RX-3 Warrants were exercised in full, and (iv) all of the shares of Issuer common stock issuable upon conversion of the shares of Series RX-3 preferred stock issuable pursuant to such RX-3 Warrants were so issued, and (v) assuming exercise of all other outstanding Issuer warrants and convertible securities (whether or not presently exercisable or exercisable within 60 days) would be 17.48%.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
MEMBRADO MICHAEL M 165 OLD POST ROAD BEDFORD CORNERS, NY 10549		X

Signatures
Michael M. Membrado		6/25/2019
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.